#Randomization

GUANZON has the properties of both RUBBER and GUM

soRANDOMIZATION IN TTRPGsI think a lot about:- the Role of Randomization in Games- D&D Without Dice- Belonging Outside Belonging We touch on what Luck does in games in The Consequences

(1/12) I receive emails warning about hackers targeting COVID data. Huge issues..it’s a crime and a danger to trial integrity. But also begs another discussion…if your loved one could be

Ricky Turgeon PharmD

It looks like we have the (preliminary, preprint) results of our first RCT of renin-angiotensin blockers for the treatment of COVID-19. Some of my early thoughts 1/https://www.medrxiv.org/content/10.1101/2020.08.04.20167205v1 2/ First, the

Chris "Early Treatment" Martenson, PhD

The TOGETHER trial purports to show that Ivermectin doesn't provide any benefit. It's given top billing in the NEJM and is now splashed everywhere on the medical news. It's a

Ashish K. Jha, MD, MPH

Dexamethasone RecoveryTrial data outNot yet peer-reviewed but thank goodness for preprintA few reflections1. The randomization worked. The groups were pretty balanced2. They pre-specified their subgroups. That's importantSo the results?

Angus Deaton's article, just published in @TheIndiaForum on 'randomization in the tropics': https://www.theindiaforum.in/article/randomization-tropics-revisited @ramreddy As frequently, I disagree with Deaton on certain points, for instan

the heart of this Google/Apple contact tracing proposal seems to harken back to the bad old days of Bluetooth wardriving, where you could sniff the unique ID being emitted by

Vinay Prasad MD MPH

This idea of allowing some people access to an investigational vaccine WHILE a randomized trial is ongoing is not a serious proposalThe fact it is made on twitter & a

1/ Here are the relative effects (Y axis) and the p-values (X axis) found for all the 6 clinical outcomes measured by the 3 outpatient RCTs of HCQ for covid

Benjamin Rome, MD

Alright, we finally have some data from the ACTT-1 remdesivir trial, published as a prelim report in @NEJM Some initial thoughts https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home The randomization was stratified by sev

george davey smith

Below is the start of a thread by a geneticist on discovering that the most extreme single genetic variant he can find in @GWASCatalog actually tells you about the huge

Jean-Claude Fox

Concerning the matter of "re-opening" the country, it's interesting to watch the different approaches in Germany v the USA. In the USA, the debate appears to be quite binary: Reopen,

Dr Ellie Murray

Today’s #tweetorial—positivity for #causalinference: what it is and why it matters. First, what it’s not: the type of positivity Im going to talk about is not a positive mental attitude!

Alex John London

1. My new paper with @kimmelmanJ is out at @ScienceMagazine. “Pandemic Research Exceptionalism” is the idea that the urgency of a crisis warrants lowering #research standards. We argue against this

Michael P. Hengartner, PhD

I am still a bit puzzled, how fiercly some psychiatrists debated the conclusion of my recent paper, that in depression relapse prevention trials preventive effects and withdrawal effects are severely

(1/n) Saw this letter in @NEJM…also covered by journalists. Concurrent vs non-concurrent controls is a complex issue in platform trials. This is a tweetorial on these issues, and a comment